{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:01:50Z","timestamp":1787508110291,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Health & Welfare, Republic of Korea","award":["Grant\/Award No. HI16C1559"],"award-info":[{"award-number":["Grant\/Award No. HI16C1559"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1348-0","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:04:29Z","timestamp":1565327069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves\u2019 ophthalmopathy"],"prefix":"10.1186","volume":"10","author":[{"given":"Mira","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinYoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"issue":"17","key":"1348_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"Weetman AP. Graves\u2019 disease. N Engl J Med. 2000;343(17):1236\u201348.","journal-title":"N Engl J Med"},{"issue":"3","key":"1348_CR2","first-page":"998","volume":"83","author":"RS Bahn","year":"1998","unstructured":"Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves\u2019 orbital adipose\/connective tissues: potential autoantigen in Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab. 1998;83(3):998\u20131002.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1348_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF03350193","volume":"11","author":"WM Wiersinga","year":"1988","unstructured":"Wiersinga WM, Smit T, van der Gaag R, Koornneef L. Temporal relationship between onset of Graves\u2019 ophthalmopathy and onset of thyroidal Graves\u2019 disease. J Endocrinol Investig. 1988;11(8):615\u20139.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1348_CR4","doi-asserted-by":"publisher","first-page":"17533","DOI":"10.1038\/s41598-017-17893-y","volume":"7","author":"YJ Li","year":"2017","unstructured":"Li YJ, Luo Y, Xie XQ, He WM, Yi C, Li P, et al. The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response. Sci Rep. 2017;7(1):17533.","journal-title":"Sci Rep"},{"issue":"2","key":"1348_CR5","first-page":"168","volume":"21","author":"L Bartalena","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C. Management of Graves\u2019 ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21(2):168\u201399.","journal-title":"Endocr Rev"},{"issue":"6","key":"1348_CR6","first-page":"747","volume":"14","author":"HB Burch","year":"1993","unstructured":"Burch HB, Wartofsky L. Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14(6):747\u201393.","journal-title":"Endocr Rev"},{"issue":"1","key":"1348_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","volume":"82","author":"C Matthiesen","year":"2012","unstructured":"Matthiesen C, Thompson JS, Thompson D, Farris B, Wilkes B, Ahmad S, et al. The efficacy of radiation therapy in the treatment of Graves\u2019 orbitopathy. Int J Radiat Oncol Biol Phys. 2012;82(1):117\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1348_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","volume":"51","author":"SD Marquez","year":"2001","unstructured":"Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, et al. Long-term results of irradiation for patients with progressive Graves\u2019 ophthalmopathy. Int J Radiat Oncol Biol Phys. 2001;51(3):766\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"1348_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1055\/a-0739-8134","volume":"50","author":"A Kotwal","year":"2018","unstructured":"Kotwal A, Stan M. Current and future treatments for Graves\u2019 disease and Graves\u2019 ophthalmopathy. Horm Metab Res. 2018;50(12):871\u201386.","journal-title":"Horm Metab Res"},{"key":"1348_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-pharmtox-010617-052509","volume":"59","author":"TJ Smith","year":"2019","unstructured":"Smith TJ. Challenges in orphan drug development: identification of effective therapy for thyroid-associated pphthalmopathy. Annu Rev Pharmacol Toxicol. 2019;59:129\u201348.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5\u20136","key":"1348_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"S Meirelles Lda","year":"2009","unstructured":"Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5\u20136):419\u201327.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"1348_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jcyt.2015.10.013","volume":"18","author":"JM Koch","year":"2016","unstructured":"Koch JM, D\u2019Souza SS, Schwahn DJ, Dixon I, Hacker TA. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice. Cytotherapy. 2016;18(2):219\u201328.","journal-title":"Cytotherapy."},{"issue":"12","key":"1348_CR13","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/jnr.23616","volume":"93","author":"HW Park","year":"2015","unstructured":"Park HW, Moon HE, Kim HS, Paek SL, Kim Y, Chang JW, et al. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain. J Neurosci Res. 2015;93(12):1814\u201325.","journal-title":"J Neurosci Res"},{"issue":"10","key":"1348_CR14","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/jcp.24981","volume":"230","author":"W Huang","year":"2015","unstructured":"Huang W, Lv B, Zeng H, Shi D, Liu Y, Chen F, et al. Paracrine factors secreted by MSCs promote astrocyte survival associated with GFAP downregulation after ischemic stroke via p38 MAPK and JNK. J Cell Physiol. 2015;230(10):2461\u201375.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1348_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1542-0124(12)70062-9","volume":"2","author":"CS Bouchard","year":"2004","unstructured":"Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocul Surf. 2004;2(3):201\u201311.","journal-title":"Ocul Surf"},{"issue":"7\u20138","key":"1348_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.drudis.2010.02.001","volume":"15","author":"S Ahmad","year":"2010","unstructured":"Ahmad S, Kolli S, Lako M, Figueiredo F, Daniels JT. Stem cell therapies for ocular surface disease. Drug Discov Today. 2010;15(7\u20138):306\u201313.","journal-title":"Drug Discov Today"},{"issue":"4","key":"1348_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/MIB.0b013e31827f27df","volume":"19","author":"L Mayer","year":"2013","unstructured":"Mayer L, Pandak WM, Melmed GY, Hanauer SB, Johnson K, Payne D, et al. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn\u2019s disease: a phase 1 study. Inflamm Bowel Dis. 2013;19(4):754\u201360.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1348_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord. 2014;3(6):696\u2013704.","journal-title":"Mult Scler Relat Disord"},{"key":"1348_CR19","unstructured":"Baughman RP, Culver DA, Jankovi V, Fischkoff S, Brockway G, Lower EE. Placenta-derived mesenchymal like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32(2):106\u201314."},{"issue":"9","key":"1348_CR20","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1210\/en.2013-1576","volume":"154","author":"S Moshkelgosha","year":"2013","unstructured":"Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation. Endocrinology. 2013;154(9):3008\u201315.","journal-title":"Endocrinology."},{"issue":"4","key":"1348_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1210\/en.2015-1829","volume":"157","author":"U Berchner-Pfannschmidt","year":"2016","unstructured":"Berchner-Pfannschmidt U, Moshkelgosha S, Diaz-Cano S, Edelmann B, Gortz GE, Horstmann M, et al. Comparative assessment of female mouse model of Graves\u2019 orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigen. Endocrinology. 2016;157(4):1673\u201382.","journal-title":"Endocrinology."},{"issue":"1","key":"1348_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jcb.22728","volume":"112","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Cha KE, Hwang SG, Kim JK, Kim GJ. In vitro screening system for hepatotoxicity: comparison of bone-marrow-derived mesenchymal stem cells and placenta-derived stem cells. J Cell Biochem. 2011;112(1):49\u201358.","journal-title":"J Cell Biochem"},{"issue":"2","key":"1348_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/jc.2013-1004","volume":"98","author":"TJ Smith","year":"2013","unstructured":"Smith TJ. Is IGF-I receptor a target for autoantibody generation in Graves\u2019 disease? J Clin Endocrinol Metab. 2013;98(2):515\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1348_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/s-0035-1559633","volume":"47","author":"SA Morshed","year":"2015","unstructured":"Morshed SA, Davies TF. Graves\u2019 disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies. Horm Metab Res. 2015;47(10):727\u201334.","journal-title":"Horm Metab Res"},{"issue":"20","key":"1348_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn RS, Heufelder AE. Pathogenesis of Graves\u2019 ophthalmopathy. N Engl J Med. 1993;329(20):1468\u201375.","journal-title":"N Engl J Med"},{"issue":"4","key":"1348_CR26","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1210\/en.2011-1846","volume":"153","author":"M Nakahara","year":"2012","unstructured":"Nakahara M, Johnson K, Eckstein A, Taguchi R, Yamada M, Abiru N, et al. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice. Endocrinology. 2012;153(4):2034\u201342.","journal-title":"Endocrinology."},{"issue":"8","key":"1348_CR27","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.4049\/jimmunol.176.8.5084","volume":"176","author":"JA Gilbert","year":"2006","unstructured":"Gilbert JA, Gianoukakis AG, Salehi S, Moorhead J, Rao PV, Khan MZ, et al. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves\u2019 disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J Immunol. 2006;176(8):5084\u201392.","journal-title":"J Immunol"},{"issue":"10","key":"1348_CR28","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1167\/iovs.15-16580","volume":"56","author":"K Kozdon","year":"2015","unstructured":"Kozdon K, Fitchett C, Rose GE, Ezra DG, Bailly M. Mesenchymal stem cell-like properties of orbital fibroblasts in Graves\u2019 orbitopathy. Invest Ophthalmol Vis Sci. 2015;56(10):5743\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1348_CR29","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1167\/iovs.15-16610","volume":"56","author":"S Brandau","year":"2015","unstructured":"Brandau S, Bruderek K, Hestermann K, Gortz GE, Horstmann M, Mattheis S, et al. Orbital fibroblasts from Graves\u2019 orbitopathy patients share functional and immunophenotypic properties with mesenchymal stem\/stromal cells. Invest Ophthalmol Vis Sci. 2015;56(11):6549\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1348_CR30","doi-asserted-by":"publisher","first-page":"3932615","DOI":"10.1155\/2018\/3932615","volume":"2018","author":"S Nepali","year":"2018","unstructured":"Nepali S, Park M, Lew H, Kim O. Comparative analysis of human adipose-derived mesenchymal stem cells from orbital and abdominal fat. Stem Cells Int. 2018;2018:3932615.","journal-title":"Stem Cells Int"},{"issue":"3","key":"1348_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.beem.2011.11.009","volume":"26","author":"W Muller-Forell","year":"2012","unstructured":"Muller-Forell W, Kahaly GJ. Neuroimaging of Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):259\u201371.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"1348_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.sjopt.2017.09.003","volume":"32","author":"I San Miguel","year":"2018","unstructured":"San Miguel I, Arenas M, Carmona R, Rutllan J, Medina-Rivero F, Lara P. Review of the treatment of Graves\u2019 ophthalmopathy: the role of the new radiation techniques. Saudi J Ophthalmol. 2018;32(2):139\u201345.","journal-title":"Saudi J Ophthalmol"},{"issue":"2","key":"1348_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ijrobp.2006.06.004","volume":"66","author":"M Arenas","year":"2006","unstructured":"Arenas M, Gil F, Gironella M, Hernandez V, Jorcano S, Biete A, et al. Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice. Int J Radiat Oncol Biol Phys. 2006;66(2):560\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1348_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.rpor.2016.02.001","volume":"21","author":"M Arenas","year":"2016","unstructured":"Arenas M, Sabater S, Jimenez PL, Rovirosa A, Biete A, Linares V, et al. Radiotherapy for Graves\u2019 disease. The possible role of low-dose radiotherapy. Rep Pract Oncol Radiother. 2016;21(3):213\u20138.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"8","key":"1348_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/1050725041692918","volume":"14","author":"J Sanders","year":"2004","unstructured":"Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid. 2004;14(8):560\u201370.","journal-title":"Thyroid."},{"issue":"3","key":"1348_CR36","doi-asserted-by":"publisher","first-page":"e1441","DOI":"10.1002\/term.2561","volume":"12","author":"M Park","year":"2018","unstructured":"Park M, Kim HC, Kim O, Lew H. Human placenta mesenchymal stem cells promote axon survival following optic nerve compression through activation of NF-kappaB pathway. J Tissue Eng Regen Med. 2018;12(3):e1441\u2013e49.","journal-title":"J Tissue Eng Regen Med"},{"issue":"10","key":"1348_CR37","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838\u201343.","journal-title":"Blood."},{"issue":"9","key":"1348_CR38","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"M Krampera","year":"2003","unstructured":"Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101(9):3722\u20139.","journal-title":"Blood."},{"issue":"3","key":"1348_CR39","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/eji.200838812","volume":"39","author":"L Martinet","year":"2009","unstructured":"Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fournie JJ, et al. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells. Eur J Immunol. 2009;39(3):752\u201362.","journal-title":"Eur J Immunol"},{"issue":"4","key":"1348_CR40","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1189\/jlb.0307140","volume":"82","author":"I Rasmusson","year":"2007","unstructured":"Rasmusson I, Uhlin M, Le Blanc K, Levitsky V. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol. 2007;82(4):887\u201393.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1348_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367\u201372.","journal-title":"Blood."},{"issue":"2","key":"1348_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1634\/stemcells.2007-0528","volume":"26","author":"E Traggiai","year":"2008","unstructured":"Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells. 2008;26(2):562\u20139.","journal-title":"Stem Cells"},{"issue":"1","key":"1348_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24(1):74\u201385.","journal-title":"Stem Cells"},{"issue":"4","key":"1348_CR44","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","volume":"107","author":"GM Spaggiari","year":"2006","unstructured":"Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006;107(4):1484\u201390.","journal-title":"Blood."},{"issue":"4","key":"1348_CR45","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815\u201322.","journal-title":"Blood."},{"issue":"1","key":"1348_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42\u20139.","journal-title":"Nat Med"},{"issue":"13","key":"1348_CR47","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1182\/blood-2008-07-166892","volume":"112","author":"M Rafei","year":"2008","unstructured":"Rafei M, Hsieh J, Fortier S, Li M, Yuan S, Birman E, et al. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood. 2008;112(13):4991\u20138.","journal-title":"Blood."},{"issue":"2","key":"1348_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.15283\/ijsc18031","volume":"11","author":"SH Kim","year":"2018","unstructured":"Kim SH, Jung J, Cho KJ, Choi JH, Lee HS, Kim GJ, et al. Immunomodulatory effects of placenta-derived mesenchymal stem cells on T cells by regulation of FoxP3 expression. Int J Stem Cells. 2018;11(2):196\u2013204.","journal-title":"Int J Stem Cells"},{"issue":"5411","key":"1348_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137.","journal-title":"Science."},{"issue":"7","key":"1348_CR50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0047-6374(01)00224-X","volume":"122","author":"MS Rao","year":"2001","unstructured":"Rao MS, Mattson MP. Stem cells and aging: expanding the possibilities. Mech Ageing Dev. 2001;122(7):713\u201334.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"1348_CR51","doi-asserted-by":"publisher","first-page":"e86621","DOI":"10.1371\/journal.pone.0086621","volume":"9","author":"A Shehadah","year":"2014","unstructured":"Shehadah A, Chen J, Pal A, He S, Zeitlin A, Cui X, et al. Human placenta-derived adherent cell treatment of experimental stroke promotes functional recovery after stroke in young adult and older rats. PLoS One. 2014;9(1):e86621.","journal-title":"PLoS One"},{"issue":"4\u20135","key":"1348_CR52","first-page":"217","volume":"13","author":"A Nasef","year":"2007","unstructured":"Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, et al. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr. 2007;13(4\u20135):217\u201326.","journal-title":"Gene Expr"},{"issue":"2","key":"1348_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84(2):231\u20137.","journal-title":"Transplantation."},{"issue":"4","key":"1348_CR54","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/14653240802105299","volume":"10","author":"R Rizzo","year":"2008","unstructured":"Rizzo R, Campioni D, Stignani M, Melchiorri L, Bagnara GP, Bonsi L, et al. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy. 2008;10(4):364\u201375.","journal-title":"Cytotherapy."},{"issue":"1\u20132","key":"1348_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2008.06.002","volume":"253","author":"A Nasef","year":"2008","unstructured":"Nasef A, Mazurier C, Bouchet S, Francois S, Chapel A, Thierry D, et al. Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol. 2008;253(1\u20132):16\u201322.","journal-title":"Cell Immunol"},{"issue":"3","key":"1348_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","volume":"36","author":"M Di Ianni","year":"2008","unstructured":"Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D, et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol. 2008;36(3):309\u201318.","journal-title":"Exp Hematol"},{"issue":"4","key":"1348_CR57","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1167\/iovs.05-0787","volume":"47","author":"M Wang","year":"2006","unstructured":"Wang M, Yoshida A, Kawashima H, Ishizaki M, Takahashi H, Hori J. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber. Invest Ophthalmol Vis Sci. 2006;47(4):1522\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9419","key":"1348_CR58","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439\u201341.","journal-title":"Lancet."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1348-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T19:21:01Z","timestamp":1596828061000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1348-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1348-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The process of obtaining orbital adipose tissue was approved by the Institutional Review Board of Bundang CHA Medical Center (Seongnam-si, South Korea), and the animal protocol was approved by the Institutional Animal Care and Use Committee of CHA Bundang Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}